课题基金 / 基金详情

Use of eukaryotic algae to deliver inexpensive human proteins for the treatment of Type 1 diabetes

Use of eukaryotic algae to deliver inexpensive human proteins for the treatment of Type 1 diabetes
利用真核藻类提供廉价的人类蛋白质来治疗 1 型糖尿病
批准号:
336392-2006
负责人:
Ma, Shengwu
金额:
$7.03万
依托单位国家:
加拿大
项目类别:
Strategic Projects - Group
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-01-01 至 2009-12-31

项目摘要

项目成果

Ma, Shengwu的其他基金

相似基金

相关文献

中文摘要
翻译
这项提议旨在开发一种强大的新表达系统,以生产和输送廉价和高质量的人类治疗性蛋白,用于治疗1型糖尿病。新的表达系统是基于绿藻的叶绿体转化利用。叶绿体是绿藻和植物细胞中发现的一种膜结合细胞器,负责进行光合作用。在绿藻和高等植物中,每个细胞都有许多拷贝的叶绿体DNA,因此,由于转化DNA的高拷贝数扩增,叶绿体转化具有产生大量外源蛋白的潜力。
英文摘要
This proposal aims to develop a powerful new expression system to produce and deliver inexpensive and high quantities of human therapeutic proteins for the treatment of Type 1 diabetes. The new expression system is based on the utilization of green algae by means of chloroplast transformation. The chloroplast is a membrane-bound organelle found in green algae and plant cells that conducts photosynthesis. There are many copies of chloroplast DNA per cell in both green algae and higher plants, and therefore chloroplast transformation has the potential to generate large amounts of foreign proteins due to the high copy number amplification of the transforming DNA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use of eukaryotic algae to deliver inexpensive human proteins for the treatment of Type 1 diabetes
  • 批准号:
    336392-2006
  • 项目类别:
    Strategic Projects - Group
  • 资助金额:
    $6.45万
  • 财政年份:
    2007
  • 负责人:
    Ma, Shengwu
  • 依托单位:
Use of eukaryotic algae to deliver inexpensive human proteins for the treatment of Type 1 diabetes
  • 批准号:
    336392-2006
  • 项目类别:
    Strategic Projects - Group
  • 资助金额:
    $7.03万
  • 财政年份:
    2006
  • 负责人:
    Ma, Shengwu
  • 依托单位:
Expression of human antoantigen in transgenic plants to prevent autoimmune diabetes by oral immune tolerance
  • 批准号:
    228070-2005
  • 项目类别:
    Discovery Grants Program - Group
  • 资助金额:
    $1.81万
  • 财政年份:
    2005
  • 负责人:
    Ma, Shengwu
  • 依托单位:
Transgenic plant production of human protein and human protein-cholera toxin (CTB) fusion proteins for the immunotherapy of autoimmune diseases
  • 批准号:
    228070-2001
  • 项目类别:
    Discovery Grants Program - Group
  • 资助金额:
    $1.31万
  • 财政年份:
    2003
  • 负责人:
    Ma, Shengwu
  • 依托单位:
国内基金
海外基金
白质消融性白质脑病中胶质细胞选择性受累的机制研究
  • 批准号:
    30872793
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2008
  • 负责人:
    吴晔
  • 依托单位:
白质消融性白质脑病致病基因EIF2B5的突变功能研究
  • 批准号:
    30772355
  • 项目类别:
    面上项目
  • 资助金额:
    29.0万元
  • 批准年份:
    2007
  • 负责人:
    姜玉武
  • 依托单位: